Show simple item record

FieldValueLanguage
dc.contributor.authorBusse, Madleen
dc.contributor.authorWindsor, Madeline S. A.
dc.contributor.authorTefay, Alexander J.
dc.contributor.authorKardashinsky, Mingyue
dc.contributor.authorFenton, Jacob M.
dc.contributor.authorMorrison, Daniel E.
dc.contributor.authorHarris, Hugh H.
dc.contributor.authorRendina, Louis M.
dc.date.accessioned2019-12-20
dc.date.available2019-12-20
dc.date.issued2017-12-01
dc.identifier.citationJournal of Inorganic Biochemistry 177 (2017) 313–321314en_AU
dc.identifier.urihttps://hdl.handle.net/2123/21605
dc.description.abstractThe synthesis of a series of bifunctional Gd(III) complexes 1–3 covalently bound to arylphosphonium cations possessing a varying degree of delocalisation at the phosphonium centre is presented. The influence of the degree of delocalisation was investigated with regards to in vitro cytotoxicity, cellular uptake of Gd, tumor-cell selectivity and intracellular localisation of Gd within human glioblastoma (T98G) and human glial (SVG p12) cells. Cellular uptake and selectivity studies for the Gd(III) complexes indicate that a reduced delocalisation at the phosphonium centre can lead to an enhanced Gd uptake into SVG p12 cells which results in a decrease in the overall tumor cell selectivity. Synchrotron X-ray fluorescence (microbeam XRF) imaging has demonstrated for the first time that uniform uptake of Gd(III) complex 2 within a population of T98G cells increased as a function of increasing Gd incubation times. The Gd maps show dispersed spots of high intensity which are consistent with mitochondrial uptake.en_AU
dc.description.sponsorshipAustralian Research Council (ARC DP120100958 and ARC DP140100176)en_AU
dc.language.isoenen_AU
dc.publisherElsevieren_AU
dc.relationARC DP120100958en_AU
dc.subjectmitochondriaen_AU
dc.subjectgadoliniumen_AU
dc.subjectphosphoniumen_AU
dc.subjectglioblastomaen_AU
dc.subjectXRF imagingen_AU
dc.titleTumor cell uptake and selectivity of gadolinium(III)-phosphonium complexes: The role of delocalisation at the phosphonium centreen_AU
dc.typeArticleen_AU
dc.subject.asrcFoR::030201 - Bioinorganic Chemistryen_AU
dc.subject.asrcFoR::030299 - Inorganic Chemistry not elsewhere classifieden_AU
dc.subject.asrcFoR::111204 - Cancer Therapy (excl. Chemotherapy and Radiation Therapy)en_AU
dc.subject.asrcFoR::110302 - Clinical Chemistry (diagnostics)en_AU
dc.identifier.doi10.1016/j.jinorgbio.2017.07.004
dc.type.pubtypePost-printen_AU


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.